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Abstract. 
 
The epidermal cornified cell envelope (CE)
is a complex protein–lipid composite that replaces the
plasma membrane of terminally differentiated kerati-
nocytes. This lamellar structure is essential for the bar-
rier function of the skin and has the ability to prevent
the loss of water and ions and to protect from environ-
mental hazards. The major protein of the epidermal CE
 
is loricrin, contributing 
 
z
 
70% by mass. We have gener-
ated mice that are deficient for this protein. These mice
showed a delay in the formation of the skin barrier in
embryonic development. At birth, homozygous mutant
mice weighed less than control littermates and showed
skin abnormalities, such as congenital erythroderma
with a shiny, translucent skin. Tape stripping experi-
ments suggested that the stratum corneum stability was
 
reduced in newborn Lor
 
2
 
/
 
2
 
 mice compared with wild-
type controls. Isolated mutant CEs were more easily
fragmented by sonication in vitro, indicating a greater
susceptibility to mechanical stress. Nevertheless, we did
not detect impaired epidermal barrier function in these
 
mice. Surprisingly, the skin phenotype disappeared
4–5 d after birth. At least one of the compensatory
mechanisms preventing a more severe skin phenotype
in newborn Lor
 
2
 
/
 
2
 
 mice is an increase in the expression
of other CE components, such as SPRRP2D and
SPRRP2H, members of the family of “small proline
rich proteins”, and repetin, a member of the “fused
gene” subgroup of the S100 gene family.
Key words: loricrin • knockout mice • cornified enve-
lope • small proline-rich protein • repetin 
 
Introduction
 
The cornified cell envelope (CE)
 
1
 
 is a protein–lipid layer
that replaces the plasma membrane of corneocytes and is
crucial for epidermal barrier function (Roop, 1995). The
CE consists of a complex mixture of covalently cross-
linked proteins and a layer of characteristic lipids attached
to the extracellular surface of the protein layer (Wertz et
al., 1989; Steinert and Marekov, 1995; Ishida-Yamamoto
and Iizuka, 1998; Marekov and Steinert, 1998; Steinert et
al., 1998a,b). On the cytoplasmic side, keratin filaments
and their attachment sites at the plasma membrane, the
desmosomes, are embedded in the CE (Koch and Franke,
 
1994). The CE components are cross-linked mainly via
 
e
 
-(
 
g
 
-glutamyl)lysine isopeptide bonds, which are catalyzed
by calcium-dependent transglutaminases (TGases). This
cross-linking leads to a protein complex that is highly insol-
uble and resistant to conventional biochemical extraction
procedures. The significance of the TGase-mediated cross-
linking for skin function has been demonstrated by the dis-
covery that mutations in one of these enzymes (TGase 1)
can lead to lamellar ichthyosis, an autosomal recessive skin
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disease (Russell et al., 1995; Huber et al., 1995, 1997). Pa-
tients with this severe disease develop hyperkeratosis
(thickening of the stratum corneum) and acanthosis (thick-
ening of the epidermis) due to a failure to form CE (Jeon
et al., 1998). Furthermore, mice that are deficient for
TGase 1 exhibit a severe defect in epidermal barrier func-
tion resulting in neonatal lethality (Matsuki et al., 1998).
Several protein components of the CE have been identi-
fied, among them are involucrin, members of a family of
small proline-rich proteins (SPRRPs), loricrin as well as
cystatin 
 
a
 
, desmoplakin, envoplakin, elafin, filaggrin, and
several keratins (Ishida-Yamamoto and Iizuka, 1998).
Furthermore, repetin has been identified as a putative CE
precursor protein (Krieg et al., 1997).
 
 
 
Some of these pro-
teins (involucrin, SPRRPs, loricrin, filaggrin, and repetin)
are encoded by genes clustered in the so-called “epidermal
differentiation complex” on human chromosome 1q21
(Volz et al., 1993; Marenholz et al., 1996; Mischke et al.,
1996) and mouse chromosome 3 (Rothnagel et al., 1994;
Song et al., 1999), respectively. Involucrin, SPRRPs, repe-
tin, and loricrin also share amino acid sequence homolo-
gies in their COOH-terminal domains, indicating a com-
mon origin of these genes (Backendorf and Hohl, 1992;
Krieg et al., 1997)
Interestingly, the protein composition of the CE varies
between different tissues and body sites. Loricrin is the
major component of the CE in the interfollicular epider-
mis, in which as much as 70% of the CE mass is derived
from this protein (Hohl et al., 1991; Steven and Steinert,
1994; Jarnik et al., 1996; Steinert et al., 1998a). For exam-
ple, in human foreskin epidermis, the inner (cytoplasmic)
two thirds of the CE consists of 
 
.
 
85% of loricrin (Steinert
and Marekov, 1995). On the other hand, loricrin is absent
in most internal epithelia, though one notable exception is
the mouse forestomach (Hohl et al., 1993). Furthermore,
the molar ratio of the CE components may vary between
different tissues. A comparison of mouse epidermal and
forestomach CE showed that the ratio of loricrin to
SPRRPs was 100:1 in the newborn epidermis and 3:1 in the
forestomach (Jarnik et al., 1996; Steinert et al., 1998a).
SPRRP proteins are coexpressed with loricrin and serve as
molecular cross-linkers (Steinert et al., 1998a). It has been
speculated that the relative molar ratio of loricrin and
SPRRP proteins may determine the biomechanical prop-
erties of the CE. For example, CE that are subject to
mechanical stress may have a higher relative amount of
SPRRP proteins (Jarnik et al., 1996; Steinert et al., 1998a).
It has been proposed that the first step in epidermal CE
formation in the stratum granulosum is the deposition of
involucrin at the inner surface of the plasma membrane
(Steinert and Marekov, 1997). Involucrin is thought to
serve as a scaffold for the addition of other CE compo-
nents (Steinert and Marekov, 1997). Loricrin (Mehrel et
al., 1990) is expressed in the granular layer of the epider-
mis where it accumulates in granules (termed L-granules
to differentiate them from profilaggrin-containing F-gran-
ules) before it is integrated into the developing CE
(Steven et al., 1990; Bickenbach et al., 1995).
Mouse loricrin is a glycine- (55.1% of total amino acids),
serine- (22.3%), and cysteine-rich (7.1%) basic protein. It
consists of 481 amino acids and has a predicted molecular
weight of 37,828 (Mehrel et al., 1990). The protein con-
 
tains tandem repeats that have been predicted to form
“glycine loops” (Hohl et al., 1991; Steinert et al., 1991). It
is thought that these structures confer flexibility to the
protein and the CE. Interestingly, these biochemical fea-
tures of loricrin, glycine-rich sequences and high flexibil-
ity, are also characteristic for the NH
 
2
 
-terminal and
COOH-terminal domains of keratins 1 and 10 (Jorcano et
al., 1984; Zhou et al., 1988). This pair of intermediate fila-
ment proteins is coexpressed with loricrin in embryonic
development of the epidermis (Bickenbach et al., 1995).
The glycine loops of loricrin are flanked by glutamine- or
glutamine/lysine-rich sequences, which are targets for
TGase-mediated intramolecular and intermolecular cross-
linking through isopeptide bonds (Steinert and Marekov,
1995). The abundance of cysteine residues in the loricrin
sequence suggests that this protein also forms extensive
disulfide bridges (Hohl et al., 1991). This prediction is sup-
ported by the observation that loricrin can only be solubi-
lized with high concentrations of reducing agents (Mehrel
et al., 1990).
The unique structural features of loricrin and its abun-
dance in orthokeratinizing epithelia, in particular tissues
that are subject to considerable mechanical stress, such as
the epidermis and forestomach (in mouse), have led to the
assumption that expression of this protein is essential for
the function of these tissues. To test this hypothesis, we
have generated loricrin knockout mice. Unexpectedly, loss
of loricrin led to a mild transient phenotype in mice. We
present evidence suggesting that Lor
 
2
 
/
 
2
 
 mice compensate
for the loss of the main epidermal CE component by up-
regulating the expression of other CE components, in par-
ticular SPRRPs and repetin.
 
Materials and Methods
 
Construction of Targeting Vector
 
We have described previously the isolation and characterization of the lori-
crin gene of the BALB/c mouse strain (Rothnagel et al., 1994). To achieve
a high frequency of recombination with the genome of mouse embryonic
stem (ES) cells, gene targeting/replacement vectors were constructed using
gene sequences from the 129/Sv mouse strain (Capecchi, 1989; Deng and
Capecchi, 1992; Ramirez-Solis et al., 1993; Horie et al., 1994). We have iso-
lated the loricrin gene from this mouse strain. In our targeting vector (Fig.
1 A), a 2.457-kb DNA fragment encompassing the entire loricrin coding se-
quence is deleted and replaced by a neomycin-resistance minigene (see Fig.
1 A, PGKneobpA) (provided by Allan Bradley, Baylor College of Medi-
cine). The minigene is flanked by DNA sequences derived from the loricrin
gene locus (5.8-kb 5
 
9 
 
flanking sequence; 1.5-kb 3
 
9 
 
flanking sequence). To
facilitate the isolation of targeted ES cell clones, we inserted a herpes sim-
plex virus type 1 thymidine-kinase minigene (HSV-tk, Fig. 1 A) (Mansour
et al., 1988) into the targeting vector (provided by John Lydon, Baylor Col-
lege of Medicine). Both minigenes are under the transcriptional control of
the phosphoglycerate kinase I promotor.
 
Targeting of ES Cells and Generation of
Loricrin-deficient Mice
 
The ES cell line AB2.2 (provided by Allan Bradley, Baylor College of
Medicine) was cultured as described previously (Ramirez-Solis et al.,
1993). Linearized targeting vector was introduced into ES cells by elec-
troporation with a Bio-Rad Gene Pulser II (Bio-Rad Laboratories). Elec-
troporated ES cells were grown on gamma-irradiated neomycin-resistant
SNL feeder cells (Hogan et al., 1994), provided by Allan Bradley (Baylor
College of Medicine) in selection medium containing G418 (GIBCO
BRL) and FIAU. G418/FIAU-resistant ES cell colonies were isolated and
screened for successful recombination using a mini-Southern procedure
(Ramirez-Solis et al., 1992, 1993). As shown in Fig. 1, we used a SacI–SphI
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fragment (5
 
9
 
 probe) and a SacI–BamHI fragment (3
 
9
 
 probe) as probes in
this Southern blot analysis. Recombinant ES cell clones that showed the
expected DNA bands in Southern blots, indicating a deletion of the lori-
crin coding sequence in one allele, were also tested with a probe derived
from the neomycin-resistance minigene. This probe indicated the pres-
ence of a single copy of the neomycin-resistance minigene in the recombi-
nant ES cell clones tested (data not shown). The recombinant ES cells
were injected into C57Bl/6J blastocysts. Chimeric offsprings were crossed
with C57Bl/6J mice. DNA from agouti offspring was prepared from the
tail (Hogan et al., 1994) and tested for the presence of the targeted allele
by Southern blot hybridization using the 5
 
9
 
 and/or 3
 
9
 
 probes. Mice het-
erozygous for the targeted mutation were intercrossed to obtain homozy-
gous loricrin-null mutants. To minimize phenotype variations due to the
mixed (129/Sv and C57Bl/6) genetic background, we crossed the loricrin-
null allele into the FvB mouse strain. The experiments described in this
paper were performed using mice from the fifth back cross.
 
Southern Blot Analysis
 
Genomic DNA from mouse tails (Hogan et al., 1994) was digested over-
night with the appropriate restriction enzymes. DNA fragments were sep-
arated by agarose gel electrophoresis, transferred to GeneScreen Plus
membranes (NEN Life Science Products), and then UV cross-linked (UV
Stratalinker 1800; Stratagene). Radioactive DNA probes were synthe-
sized using the DecaprimeII kit (Ambion) with [
 
a
 
32
 
P]dCTP (NEN Life
Science Product). Blots were hybridized for 2 h at 65
 
8
 
C with probes in
“rapid hybridization buffer” (Amersham Pharmacia Biotech), washed
once for 10 min at room temperature in 2
 
3
 
 SSC/0.1%SDS, followed by
two washes (20 min each) at 65
 
8
 
C in 0.2
 
3 
 
SSC/0.1% SDS. The membranes
were then exposed to Kodak BIOMAX MR film (Eastman Kodak).
 
RNase Protection Assay
 
The following mouse DNA clones were used to synthesize antisense
cRNA probes: loricrin (200-bp 3
 
9
 
 coding sequence), SPRRP2D (position
309–640, sequence data available from EMBL/GenBank/DDBJ under
accession number AJ005562), SPRRP2H (position 469–642, sequence
data available from EMBL/GenBank/DDBJ under accession number
AJ005566), repetin (position 8651–8854, sequence data available from
EMBL/GenBank/DDBJ under accession number X99251), 
 
b
 
-actin (pTRI-
actin M, Ambion), GAPDH (pTRI-GAPDH, Ambion), cyclophilin (Am-
bion), and desmoglein 3 (clone B9; Koch et al., 1997). Mouse epidermis
was prepared as described previously (DiSepio et al., 1999). In some ex-
periments, total RNA was isolated from epidermis with the RNAzol B re-
agent (Tel-test). Biotinylated probes were synthesized with a MAXIscript
II Kit (Ambion) using biotin-16-UTP (Enzo). The 
 
b
 
-actin probe was syn-
thesized with 1/50 of the standard biotin-16–UTP concentration to obtain
RPA signals comparable with those obtained with the other probes. For
nonradioactive RPA, tissue lysates were prepared using the Direct Protect
Kit (Ambion). RPA products were separated in 6% polyacrylamide/
TBE/8 M urea gels, blotted onto GeneScreen Plus membranes (NEN Life
Science Products) with a Mini-Trans-Blot Cell (Bio-Rad Laboratories),
and then UV cross-linked (UV Stratalinker 1800; Stratagene). Biotin-
labeled RNA fragments were detected with a chemiluminescent detection
system (BrightStar Biodetect; Ambion). RPA with radioactive labeled
probes were done with the RPAII kit (Ambion). Expression levels of
RNAs were determined by scanning RPA autoradiograms followed by
densitometric analysis with the QuantiScan software package (Biosoft).
 
Antibodies
 
The following antibodies were used: loricrin (Mehrel et al., 1990), K14
(Roop et al., 1984), repetin (Huber, M., and D. Hohl, unpublished data)
filaggrin repeat (AF 111), which was generated against synthetic peptide
DSQVHSGVQVEGRRGH (Yuspa et al., 1989), and fiaggrin linker
(AF133), which was generated against the synthetic peptide GYYYEQE-
HSEEESD. Anti–rabbit, anti–guinea pig, and anti–mouse IgG coupled to
fluorescent dyes (FITC, Texas red) were purchased from Zymed Labora-
tories and Dako.
 
Western Blotting
 
Skin samples of newborn mice were pulverized in liquid nitrogen and then
incubated for 10 min in extraction buffer (0.0625 M Tris-HCl, 5% SDS,
10% glycerol, 20% 
 
b
 
-mercaptoethanol, pH 6.8) at 95
 
8
 
C. Equal amounts of
protein were separated in 10% SDS-PAGE gels and then transferred onto
nitrocellulose membranes (S&S NC; Schleicher & Schuell) with a Mini-
Trans-Blot Cell (Bio-Rad Laboratories). Membranes were blocked for 1 h
in blocking buffer (3% nonfat milk/TBS) and then incubated with the pri-
mary antibody, which was dissolved in blocking buffer, for 1 h. After three
washes (10 min each) in TBST buffer (0.05% Tween 20 in TBS), mem-
branes were incubated with the secondary antibody (alkaline phos-
phatase–conjugated anti–rabbit or anti–mouse antibodies; Zymed Labo-
ratories) for 30 min and then washed as described above. Antibody
binding was visualized with the NBT/BCIP system (Boehringer).
 
Immunofluorescence Microscopy
 
Cryosections (5-
 
m
 
m thick) were fixed in acetone for 10 min at 
 
2
 
20
 
8
 
C and
then washed in PBS. The tissues samples were incubated with the first an-
tibody at the appropriate dilution in 1% BSA/PBS over night at 4
 
8
 
C. Af-
ter washing three times for 10 min each in PBS, samples were incubated
with a fluorescent dye–coupled antibody diluted in 1% BSA/PBS for 30
min and washed as described above. Stained sections were examined and
photographed with a Nikon OPTIPHOT photomicroscope (Nikon).
 
Preparation of CEs and Sonication Experiments
 
Epidermis from newborn and 4-d-old mice was isolated essentially as de-
scribed previously (Jarnik et al., 1996). CEs were prepared by boiling epi-
dermis for 20–40 min in a buffer consisting of 20 mM Tris-HCl, pH 7.5, 5
mM EDTA, 10 mM DTT, and 2% SDS. After centrifugation (5,000 
 
g
 
),
CEs were washed twice at room temperature with a buffer consisting of 20
mM Tris-HCl, pH 7.5, 5 mM EDTA, 10 mM DTT, and 0.2% SDS. For
sonication, CEs were suspended in a 2% SDS solution. The concentration
of CE was determined with a hemacytometer. The CE suspension was
sonicated in a Branson 2210 cup sonicator (Branson Ultrasonics) at 4
 
8
 
,
20
 
8
 
, 30
 
8
 
, and 60
 
8
 
C. At various time points, CE aliquots were removed from
the sonicator, counted with the hemacytometer, and photographed with a
Nikon OPTIPHOT photomicroscope.
 
Tape Stripping Experiments
 
Newborn mice were tape stripped 10 times. Backskin from treated and
untreated areas were excised, fixed, and processed for electron micros-
copy as described previously (Bickenbach et al., 1996).
 
Toluidine Blue Staining of Mouse Embryos
 
The developmental stage of mouse embryos was determined based on the
assumption that fertilization occurred in the middle of the dark cycle the
day before plugs were identified. The embryos were stained essentially as
described (Hardman et al., 1998). In brief, embryos were dehydrated by
incubations (1 min each) in 25%, 50%, and 75% methanol/PBS followed
by 1 min in 100% methanol. The embryos were then rehydrated with the
same series of methanol solutions (1 min incubations), washed in PBS,
and stained for 1 min in 0.0125% toluidine blue O (Fisher Scientific)/PBS.
After destaining in PBS, embryos were photographed with a Nikon
SMZ-2T microscope.
 
Measurement of Transepidermal Water Loss 
 
Transepidermal water loss (TEWL) from the ventral skin of newborn
mice was determined using a Tewameter TM210 (Courage and Khazaka),
as described previously (Matsuki et al., 1998). In addition, we used a sim-
ple dye penetration assay to analyze potential barrier defects (Matsuki et
al., 1998). In brief, the backs of mice were immersed in 1 mM Lucifer yel-
low/PBS (Fluka Chemical Co.). Mice were killed after 1 h incubation and
frozen sections were prepared from the back skin. Penetration of the dye
was analyzed using a fluorescence microscope.
 
Results
 
Cloning of the Mouse Loricrin Gene and Generation of 
Loricrin-deficient Mice
 
We have described previously the structure and chromo-
somal localization of the BALB/c loricrin gene (Rothnagel
et al., 1994). To construct an efficient gene targeting vec-
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tor, we isolated the loricrin gene from the 129Sv/J mouse
strain. It has been shown that the use of isogenic DNA can
significantly increase the efficiency of gene targeting vec-
tors in ES cells (Deng and Capecchi, 1992; Zhang et al.,
1994; Simpson, 1997).
The loricrin protein sequence is encoded by a single exon
(Yoneda et al., 1992; Rothnagel et al., 1994). In the target-
ing vector pDV140, a 2.4-kb PstI fragment encompassing
the entire loricrin coding sequence was deleted and re-
placed by a neomycin-resistance minigene (Fig. 1 A). To al-
low homologous recombination between targeting vector
and the loricrin gene in ES cells, the neomycin minigene
was flanked by 5.8-kb 5
 
9
 
 and 1.5-kb 3
 
9
 
 loricrin sequences,
respectively. Furthermore, a herpes simplex virus thymi-
dine kinase (Fig. 1 A, HSV-tk) expression cassette was in-
troduced into the targeting construct to allow a “positive/
negative” selection procedure (Mansour et al., 1988). As
shown in Fig. 1 A, successful recombination between the
targeting vector and the loricrin gene was predicted to
eliminate a BamHI site and introduce a new SacI site into
the loricrin gene locus. Neo
 
r
 
/FIAU
 
r
 
 ES cell clones were
tested for the presence/absence of these two restriction
sites by Southern blot analysis using probes that were lo-
cated outside the loricrin region used in the targeting vec-
tor (Fig. 1 B). Six independent clones that had undergone
homologous recombination at the loricrin gene locus were
identified. Southern blots hybridized with a probe derived
from the neomycin minigene indicated that these clones
had integrated a single copy of the neomycin minigene
(data not shown).
All six ES cell clones were injected into C57Bl/6J blasto-
cysts. Three clones (VIL2, VIL4, and VIL5) generated
highly chimeric mice as judged by their coat color. Two of
these clones (VIL2 and VIL5) showed germline transmis-
 
sion of the targeted loricrin allele. Lor
 
2
 
/
 
2
 
 animals generated
from both ES clones were phenotypically identical. The tar-
geted mutation was inherited according to Mendelian law
(data not shown), indicating that loricrin ablation did not
prevent prenatal development. Furthermore, Lor
 
2
 
/
 
2
 
 mice
were viable and fertile.
Initially, Lor
 
2
 
/
 
2
 
 mice were derived from Lor
 
1
 
/
 
2
 
 inter-
crosses on a segregating C57Bl/6 and 129Sv background.
To minimize possible phenotypic variations due to this
heterogeneous genetic background, we crossed the loricrin
mutation into the FVB mouse inbred strain. The experi-
ments described below were performed using animals
from the fifth generation of backcrosses. To confirm that
mice homozygous for the targeted mutation did not syn-
thesize loricrin, we performed ribonuclease protection as-
says (RPA), Western blot analysis, and indirect immuno-
fluorescence microscopy. As shown in Fig. 2, newborn
Lor
 
2
 
/
 
2
 
 mice did not express loricrin as demonstrated by
the absence of loricrin mRNA and protein.
 
Effects of Loricrin Ablation on Prenatal Development
 
Hardman and colleagues recently developed a method to
follow epidermal barrier formation in mouse embryonic
development (Hardman et al., 1998). This method is based
on the staining of embryos with a histological dye (see Ma-
terials and Methods). Impermeability of the skin for the
dye indicates maturation of the skin barrier and is accom-
panied by the development of the cornified cell layers. At
the molecular level, deposition of loricrin at the plasma
membrane coincides with dye impermeability.
Focal expression of loricrin in the skin is first detected at
embryonic day (E) 16 (Bickenbach et al., 1995; Hardman
et al., 1998). We wondered whether the ablation of loricrin
affected skin barrier formation at that stage of develop-
Figure 1. Targeting strategy and
confirmation of gene targeting
event. (A) Partial restriction en-
zyme maps and schematic repre-
sentation of the strategy used to
ablate loricrin expression in mice.
The targeting vector (pDV140,
top, arrows indicate the orienta-
tion of transcription units), the
loricrin gene of 129Sv mice (129-
wt, middle) and the recombinant
loricrin locus (129-mut, bottom)
are shown. Solid lines represent
loricrin sequences included in the
targeting vector. Thin lines repre-
sent sequences excluded from the
targeting vector. Zigzag lines
symbolize plasmid sequences.
The location of the 59 (SacI–SphI)
and 39 (SacI–BamHI) probes
used to identify the recombinant
allele in Southern blots are indi-
cated above the 129-wt gene. The dotted lines below the middle and bottom schematics indicate DNA fragments that hybridize to the 3 9 and
59 probe, respectively. In the gene targeting vector, a Pst I fragment containing the entire coding sequence of the loricrin gene (middle, solid
box) was deleted and replaced by a neomycin-resistance minigene (PGKneobpA). To facilitate the identification of recombinant ES cell
clones, we introduced an HSV-tk into the targeting vector, as well. Note that recombinantion between the targeting vector and the wild-type
loricrin gene locus deleted a BamHI site (middle, solid box) and introduced a new SacI site (in PGKneobpA cassette, bottom). (B) Example
of a Southern blot analysis. Tail DNA from the offspring of a lor1/2 intercross was cut with BamHI and hybridized to the 39 probe. The geno-
type of the mice analyzed is indicated above the lanes. Arrows indicate the position of mutant (mut) and wild-type (wt) DNA fragments.
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ment. Therefore, we examined Lor
 
2
 
/
 
2
 
 and control em-
bryos at E16.5, E17.5, and E18.5 (Fig. 3). Lor
 
1
 
/
 
2
 
 and 
 
1
 
/
 
1
 
embryos showed a similar staining pattern at E16.5, with a
large unstained area on the backskin indicating barrier for-
mation. Lor
 
2
 
/
 
2
 
 embryos showed a different staining pat-
tern. Their back skin was either completely stained or
showed smaller areas of unstained skin compared with
control animals, clearly indicating impaired barrier forma-
tion. However, at E17.5, Lor
 
2
 
/
 
2
 
 and control animals did
not show any skin staining. These results suggest that the
development of skin barrier function, at least as defined by
the staining method, is delayed in Lor
 
2
 
/
 
2
 
 mice, but reaches
wild-type level at E17.5. Nevertheless, given that Lor
 
2
 
/
 
2
 
mice are born with a skin phenotype (see below), it is quite
likely that skin barrier defects persist beyond E17.5.
 
Loricrin Knockout Mice Develop a Transient 
Congenital Erythroderma with a Shiny, 
Translucent Skin
 
Mice heterozygous for the loricrin mutation (Lor
 
1
 
/
 
2
 
) were
phenotypically indistinguishable from wild-type litter-
mates. However, Lor
 
2
 
/
 
2
 
 mice were clearly abnormal at
birth. They were runted and had a shiny, translucent skin
with signs of erythroderma (Fig. 4). To determine whether
runted Lor
 
2
 
/
 
2
 
 mice grew more slowly than control litter-
mates, we monitored their body weight. The postpartum
growth rate of Lor
 
2
 
/
 
2
 
 mice was similar to control animals
(data not shown). This suggested that food intake and di-
gestion were normal in these mice, that is the loricrin-
expressing tissues of the gastrointestinal tract were func-
tioning properly. Consequently, histological examination
did not reveal abnormalities in the tissues that are known
 
to express loricrin, oral cavity, esophagus, and forestom-
ach, of Lor
 
2
 
/
 
2
 
 mice (Hohl et al., 1993). The skin pheno-
type persisted for 
 
z
 
4–5 d and then gradually disappeared.
Histological examination of newborn Lor
 
2
 
/
 
2
 
 skin did not
reveal abnormalities with respect to thickness and proper
development and differentiation (data not shown).
 
Mechanical Properties of Lor
 
2
 
/
 
2
 
 CE
 
We next prepared CEs from wild-type and Lor
 
2
 
/
 
2
 
 new-
born epidermis. Microscopic examination revealed struc-
tural abnormalities in Lor
 
2
 
/
 
2
 
 CE (Fig. 5). It has been pro-
posed that loricrin confers flexibility to the epidermal CE.
To test whether Lor
 
2
 
/
 
2
 
 CEs were more susceptible to me-
chanical stress, we exposed purified mutant and wild-type
CE to ultrasound (Table I).
 
 
 
The percentage of intact CE
from Lor
 
2
 
/
 
2
 
 epidermis decreased dramatically after 10
Figure 2. Lack of loricrin expression in newborn
Lor2/2 mice as confirmed by immunofluores-
cence microscopy (B), Western blots (C), and
RPA (D). (A) Staining of backskin from a new-
born wild-type mouse with antibodies against
loricrin (green) and K14 (red). Overlapping ex-
pression of both proteins results in yellow fluo-
rescence. K14 protein is present in the supra-
basal layers of the epidermis although the K14
gene is only transcribed in the basal cell layer.
(B) Staining of Lor2/2 back skin. Note the lack
of loricrin staining. (C) Western blots probed
with loricrin antibody. The arrowhead points to
the loricrin band in skin extracts from wild-type
back skin. (D) RPA analysis of RNA isolated
from the epidermis of newborn pups from a
Lor1/2 intercross. GAPDH was used as an inter-
nal loading control. Note the absence of loricrin
mRNA in Lor2/2 mice.
Table I. Ultrasound Treatment of Isolated CEs from Newborn 
Lor2/2 (MT) and Wild-Type (WT) Mice
WT/MT
Treatment 48C 208C 308C 608C
None 100/100 100/100 100/100 100/100
5 min 100/100 100/100 100/100 100/100
10 min 100/50 100/100 100/100 100/100
15 min 100/0 95/90 100/95 100/95
20 min 90/0 95/90 95/95 100/95
25 min 50/0 90/50 95/90 95/90
30 min ND ND 95/90 95/90
CEs were isolated from four Lor2/2 mice and two wild-type controls. Each sample was
sonicated as indicated at four different temperatures. Numbers indicate percentage of
intact CE. 
ND, not done.
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min of ultrasound treatment (50% mutant CE versus
100% wild-type CE) (Fig. 5 and Table I). After 15 min, es-
sentially all mutant CEs were destroyed. In contrast, no
damage was evident in wild-type CE after 15 min of ultra-
sound treatment. Interestingly, the susceptibility of mu-
tant CE to ultrasound was temperature dependent. Ini-
tially, CEs were treated with ultrasound at 48C. At higher
temperature, mutant CE were partially protected from ul-
trasound damage (Table I). For example, whereas essen-
tially all mutant CEs were destroyed after 15 min treat-
ment at 48C, only 10% were damaged at 208C (Table I).
Adult Lor2/2 CE also showed the same susceptibility to
sonication (data not shown).
To determine whether the abnormal CE affected the
biomechanical properties of the mutant epidermis, we per-
formed tape stripping experiments and determined the
loss of cell layers from the stratum corneum by electron
microscopy. As summarized in Fig. 6, the stratum corneum
of Lor2/2 backskin was less resistant to mechanical stress
than wild-type control tissue. Mutant mice lost approxi-
mately three times more cell layers than control mice.
Nevertheless, the fact that tissues that are naturally ex-
posed to mechanical stress (paws, legs, and axilla) do not
show gross or microscopic lesions, suggests that the me-
chanical stability of Lor2/2 epidermis is not significantly
impaired.
The Lor2/2 Mutation Does Not Increase TEWL
We speculated that the shiny skin phenotype of Lor2/2
mice resulted from dehydration, that is an increased
TEWL due to a skin barrier defect. To investigate this pos-
sibility, we measured water loss in newborn mice with a
Tewameter (Barel and Clarys, 1995). We also determined
whether the passive diffusion of the dye Lucifer yellow
(Matsuki et al., 1998) through the stratum corneum of new-
born Lor2/2 mice was increased compared with wild-type
controls. We have shown previously that the disruption of
the epidermal barrier in transgenic mice expressing a mu-
tant form of loricrin leads to an increase in the permeabil-
ity of the skin for this dye, as well as an increase in TEWL
(Suga et al., 2000). However, neither of these methods re-
vealed an apparent increase in TEWL of Lor2/2 epidermis
(data not shown).
Upregulation of Other CE Components
in Lor2/2 Epidermis
The fast regeneration of the Lor2/2 epidermis with normal
TEWL shortly after birth and the disappearance of the
phenotype by day 4 or 5, suggested a compensatory mecha-
nism that was induced either in utero or immediately after
birth. The fact that the CE of newborn Lor2/2 mice was of
normal thickness (Jarnik, M., P.A. de Viragh, D. Bund-
man, M. Simon, D.R. Roop, and A.C. Stevens, manuscript
submitted for publication), but abnormal structure, further
supported the idea that another CE component was com-
pensating for the loss of loricrin. Therefore, we compared
the expression levels of several known CE components in
E16.5 and E17.5 embryos, newborn, and 4-d-old Lor2/2
and Lor1/1 mice. We found an increase in the expression
of repetin and two members of the SPRRPs protein family
in Lor2/2 epidermis at all time points examined (Fig. 7, A
and B), except for E16.5. At E16.5, we did not obtain de-
Figure 3. Delay in the development of the skin
barrier in Lor2/2 embryos. Embryos from lor1/2
intercrosses were extracted with methanol, which
is thought to partially extract polar lipids, and
stained with toluidine blue. Staining indicates per-
meability for the dye and shows immature barrier
function. The approximate age of the embryos
and their genotype is indicated. At E16.5, Lor1/2
embryos showed large unstained areas on the
back skin, whereas Lor2/2 embryos were com-
pletely stained, indicating a delay in the forma-
tion of the skin barrier in these embryos. Wild-
type (Lor1/1) and heterozygous mutant embryos
(Lor1/2) showed a similar staining pattern (data
not shown). At E17.5, mutant and wild-type (data
not shown) embryos were largely unstained.
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tectable signals with the repetin and SPRRP2D probe, re-
spectively. The SPRRP2H probe, however, gave reproduc-
ible signals. The expression levels of this gene were
identical in Lor2/2 and wild-type mice at E16.5 (Fig. 7 C).
SPRRPs are components of the innermost cytoplasmic
layer of the CE and serve as cross-linkers between loricrin
molecules in orthokeratinizing epithelia (see Introduc-
tion). Mouse SPRRPs constitute a family of proteins that
have been subdivided into three groups based on their
amino acid sequences: SPRRP1 (2 genes), SPRRP2 (11
genes), and SPRRP3 (1 gene) (Ishida-Yamamoto and Ii-
zuka, 1998; Song et al., 1999). Preliminary RT-PCR exper-
iments indicated that two members of the SPRRP2 sub-
family, SPRRP2D and SPRRP2H, were upregulated in
Lor2/2 epidermis (data not shown). To confirm these re-
sults, we used RPAs to determine the mRNA levels of
SPRRP2D and SPRRP2H in Lor2/2 and control (Lor1/2
and Lor1/1) back skin epidermis.
As shown in Fig. 7 A, the two SPRRP2 mRNAs were al-
ready upregulated in E17.5 embryos, z1 d after loricrin
expression is initiated in normal mice (see Introduction).
The expression of both SPRRP2D and SPRRP2H in-
creased by approximately fivefold at E17.5. The expres-
sion in newborn mice increased by fivefold (SPRRP2D)
and twofold (SPRRP2H), respectively. At day 4 of postna-
tal development, SPRRP2D and SPRRP2H expression
decreased, coinciding with the disappearance of the shiny
skin phenotype. Nevertheless, whereas both mRNAs were
easily detectable in RPA analysis of Lor2/2 skin, no
(SPRRP2D) or only faint signals (SPRRP2H) were ob-
tained using wild-type skin mRNA (Fig. 7 A).
We also examined the expression of repetin by RPA.
Repetin is a relatively new member of the “fused gene”
S100 subgroup consisting of profilaggrin, trichohyalin, and
repetin (Krieg et al., 1997). Repetin also shares homology
with CE components and was recently shown to be upreg-
Figure 4. Gross abnormalities in newborn Lor2/2 mice. (Top) Com-
parison of a Lor2/2 (top pup) and wild-type (bottom pup) newborn
mouse. Lor2/2 mice were born with a shiny, translucent skin. (Bot-
tom) This phenotype disappeared in older mice. Adult mutant (top
animal) and wild-type (bottom animal) mice were indistinguishable.
Figure 5. Morphological abnormalities and fragility of mutant
CE. Wild-type (WT) and Lor2/2 (MT) CE were isolated and
treated with ultrasound for 5, 10, 15, 20, and 25 min, respectively
(for details see Materials and Methods). Note that untreated mu-
tant CE are of irregular shape. Wild-type CE appear to be more
symmetrical and have a smooth surface. After 15 min of treat-
ment, mutant CE were completely destroyed, whereas wild-type
CE were largely intact.
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ulated along with SPRRP2A in another knockout mouse
exhibiting a barrier defect (Segre et al., 1999). Repetin
transcripts were increased approximately threefold at
E17.5, twofold in newborns, and fourfold in 4-d-old Lor2/2
back skin when compared with controls (Fig. 7 B). We
were also able to demonstrate an increase in repetin in
Lor2/2 epidermis at the protein level by immunofluores-
cence microscopy. In wild-type epidermis, repetin is ex-
pressed focally, and it appears to be localized in granules.
There is no obvious accumulation in the stratum corneum
(Fig. 8 A). However, in Lor2/2 epidermis, repetin is ex-
pressed more uniformily, and it appears to localize at the
periphery of CE in the stratum corneum (Fig. 8 B).
Other biochemical markers of keratinocyte differentia-
tion, such as profilaggrin, keratin 10, involucrin, sciellin,
and trichohyalin (which is a loricrin cross-linker in mouse
forestomach) (Steinert et al., 1998a), were expressed at
similar levels in newborn Lor2/2 and control backskin (data
not shown). However, in the case of profilaggrin, we no-
ticed an additional high molecular weight band in Western
blots from newborn Lor2/2 back skin extracts which was
not present in Lor1/1 extracts (Fig. 7 D). Profilaggrin is a
polyprotein consisting of multiple filaggrin units joined by
linker sequences and flanked by unique NH2- and COOH-
terminal domains (Rothnagel et al., 1987). The polyprotein
is processed to yield filaggrin in a complex biochemical cas-
cade involving phosphatases and proteases. Filaggrin has a
high affinity for keratins and provides a matrix in which
keratin filaments are embedded. In the stratum corneum,
filaggrin is eventually completely hydrolyzed. Free amino
acids derived from this protein are thought to contribute to
water retention in the stratum corneum.
Interestingly, one of the filaggrin antibodies used in this
study (AF133, Fig. 7 D) indicated a reduction of the
amount of mature filaggrin in Lor2/2 epidermis extracts
Figure 6. The stratum cor-
neum of Lor2/2 mice shows
increased susceptibility to
mechanical stress. The back
skin of newborn Lor2/2
(Null) and wild-type pups
was tape stripped ten times.
Animals were killed and
the number of stratum cor-
neum cell layers was deter-
mined by electron micros-
copy. Open bars (untreated
skin); closed bars (tape
stripped skin). Note that
mutant mice lost approxi-
mately three times more
cell layers.
Figure 7. Alterations in the expression of SPRRPs (A and C),
repetin (B), and of filaggrin (D) in Lor2/2 mice. RPA and Western
blot analysis were done with littermates from lor1/2 intercrosses.
(A) RPA analysis of SPRRP expression in the back skin epidermis
of E17.5 embryos, newborn, and 4-d-old pups. The genotypes of
the animals are indicated above the lanes. b-Actin, cyclophilin,
and desmoglein 3 (Dsg3; Koch et al., 1997) probes were used as in-
ternal standards. Note that the expression of SPRRP2D and
SPRRP2H was increased at all time points examined (for details
see text). (B) RPA analysis of repetin expression in the back skin
of E17.5 embryos, newborn, and 4-d-old mice. Cyclophilin was
used as an internal standard. The expression of repetin was in-
creased in Lor2/2 mice at all time points (see text for details). Note
that the repetin probe produces two bands, most likely due to a
polymorphism in the repetin gene. (C) RPA analysis of SPRRP2H
expression in the back skin epidermis of E16.5 embryos. Note sim-
ilar expression levels in mutant and wild-type mice. (D) Western
blot analysis of protein extracts from newborn back skin with anti-
bodies f111 and f133. The genotypes of the animals are indicated
above the lanes. An additional profilaggrin band was detected in
extracts from Lor2/2 mice (arrows). Note that f133 indicates a re-
duction in the amount of mature filaggrin (Fil.) in Lor2/2 mice.
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compared with Lor1/1 control extracts. However, the other
antibody (AF111, Fig. 7 D) showed equal amounts of filag-
grin in Lor2/2 and Lor1/1 extracts. Nevertheless, both anti-
bodies detected the additional high molecular band. AF133
was raised against a peptide sequence from the linker re-
gion that connects the filaggrin units in the profilaggrin pre-
cursor polypeptide (GYYYEQEHSEEESD). On the other
hand, AF111 was raised against a peptide found in the fil-
aggrin repeat (DSQVHSGVQVEGRRGH).
Therefore, the Western blot results suggest abnormal pro-
teolytic processing of profilaggrin. Immunofluorescence mi-
croscopy with AF133 showed a normal distribution of the
protein in Lor2/2 epidermis (data not shown). Furthermore,
electron microscopy on newborn epidermis showed that
Lor2/2 mice form normal profilaggrin–containing F-granules
(Jarnik, M., P.A. de Viragh, D. Bundman, M. Simon, D.R.
Roop, and A.C. Stevens, manuscript submitted for publica-
tion). It remains to be seen whether the observed aberrant
processing of profilaggrin contributes to the phenotype of
Lor2/2 mice.
Discussion
Delayed Development of Skin Barrier Function in 
Embryonic Lor2/2 Mice
Loricrin expression is first detected at day E16 in mouse
embryonic development. The protein initially accumulates
in L-granules (Bickenbach et al., 1995) where it is subse-
quently dispersed and incorporated into the nascent CE. At
this stage, a rudimentary barrier function is established. By
staining methanol-extracted E16.5 embryos with a histolog-
ical dye, a process that presumably extracts polar lipids
from the epidermis, unstained patches of skin become ap-
parent in normal mouse embryos, indicating the initiation
of barrier formation (Hardman et al., 1998). It has been
shown that deposition of loricrin into the CE correlates
with onset of dye impermeability (Hardman et al., 1998).
At E16.5, Lor2/2 embryos showed a different staining pat-
tern than control embryos, indicating impaired skin barrier
function. Their back skin was either completely stained or
Figure 8. Increased repetin expression in Lor2/2
mice. (A) Staining of back skin from a newborn wild-
type mouse with antibodies against repetin (green)
and K14 (red). Overlapping expression of both pro-
teins results in yellow fluorescence. Note the focal ex-
pression pattern and lack of accumulation in the stra-
tum corneum. (B) Staining of Lor2/2 neonatal back
skin. Note the more uniform expression pattern and
the presence of repetin at the periphery of corneo-
cytes in the stratum corneum. Also, note the appar-
ent accumulation of repetin in granules in the granu-
lar layer of both wild-type and Lor2/2 epidermis.
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showed only small patches of epidermis that were imper-
meable to the dye. In contrast, Lor1/2 and Lor1/1 embryos
showed large unstained areas on their backs (Fig. 3), and in
most cases, the entire back was unstained. However, E17.5
mutant and control back skins were equally impermeable
to the dye. Thus, the development of skin barrier function
was delayed, but not abolished, in Lor2/2 mutant embryos.
Coincident with establishment of the barrier function in
Lor2/2 embryos, we observed increased expression of cer-
tain CE components in utero (see below).
Lor2/2 Epidermis Is More Prone To Desquamation but 
Not To TEWL
Although the mutant epidermis eventually became imper-
meable to the dye, it was not completely normal. The skin
of Lor2/2 mice was red and shiny at birth, and the mutants
weighed less than 1/- and 1/1 littermates. Interestingly,
E18.5 embryos derived by cesarean section did not show
gross skin abnormalities (data not shown), indicating that
the skin phenotype developed shortly after birth, most
likely within minutes.
Based on the gross appearance of newborn Lor2/2 mice,
which was very similar to another transgenic mouse model
we characterized that exhibited dehydration due to a defect
in epidermal barrier function (Imakado et al., 1995), we ex-
pected to see an increase in TEWL. However, at the time of
measurement (z1 h after birth), we were not able to mea-
sure significant differences in TEWL in Lor2/2 neonates.
The physiological basis for the red and shiny skin remains
unclear. Staining tissue sections of Lor2/2 and control mice
with antibodies against endothelial markers did not reveal
an increase in the number or size of blood vessels in Lor2/2
mice (data not shown). Nevertheless, it is tempting to spec-
ulate that changes in the molecular composition of mutant
CE might affect the optical properties of the skin.
A significant difference between Lor2/2 and control epi-
dermis was revealed by tape striping experiments. Mutant
mice lost significantly more layers of back skin stratum
corneum cells than control mice.
Lor2/2 Cell Envelopes Show Enhanced Susceptibility to 
Mechanical Stress
The above observation suggested that the loss of loricrin
affects the biomechanical properties of the stratum cor-
neum, making it more susceptible to physical stress. This
hypothesis is supported by our sonication experiments,
which showed that purified Lor2/2 CEs were reduced to
small fragments under conditions in which wild-type CEs
remained largely intact (Table I). Although CEs isolated
from Lor2/2 mice had less regular shapes than wild-type
CEs (Fig. 5), their thickness, as determined by electron mi-
croscopy, was essentially normal, and was measured to be
z15 nm (a detailed analysis is reported in Jarnik, M., P.A.
de Viragh, D. Bundman, M. Simon, D.R. Roop, and A.C.
Stevens, manuscript submitted for publication). Since the
procedure used to isolate CEs is harsh, it may be that the
altered overall shapes of Lor2/2 CEs reflects their en-
hanced susceptibility to mechanical stress (in situ, the CE
of an individual corneocyte should be a continuous closed
bag that is ruptured and perhaps fragmented during isola-
tion).
Upregulation of SPRRP2 and Repetin in
Lor2/2 Epidermis
From the conserved thickness of the mutant CE, we sus-
pected that another CE component(s) substitutes for lori-
crin in Lor2/2 mice. Of several known CE components ex-
amined, increased transcript levels were detected only for
SPRRP2D, SPRRP2H, and repetin. SPRRPs mainly serve
as loricrin cross-linkers in orthokeratinizing epithelia. In-
terestingly, although the total amount of loricrin and
SPRRP proteins is approximately constant at 80–85% of
CE protein mass, their relative molar ratio varies markedly
between different epithelia and even between different
body sites (Jarnik et al., 1996; Steinert et al., 1998a). The
loricrin/SPRRP ratio is .100:1 in the newborn epidermis,
4.5–7.5:1 in the footpad, and 3:1 in the forestomach (Stein-
ert et al., 1998a). In general, tissues that have to withstand
higher mechanical stress seem to have more SPRRP pro-
tein. Although the elevated levels of SPRRP2 in Lor2/2
mice would imply a more robust CE, their effect appears to
be offset by other components of the mutant cell envelope.
Increased expression in Lor2/2 mice was also observed
for repetin, a recently identified member of the “fused
gene” subgroup of S100 proteins (Krieg et al., 1997). Repe-
tin is expressed in terminally differentiated keratinocytes
of mouse epidermis, tongue, and forestomach (Krieg et al.,
1997). This protein has a high content of glutamine resi-
dues (20.2%) that might serve as a substrate for TGases.
Repetin also shares sequence homologies in its COOH ter-
minus with the corresponding domains of loricrin, in-
volucrin, and SPRRP proteins (Krieg et al., 1997). These
properties, together with the observation that repetin accu-
mulates at the periphery of corneocytes in Lor2/2 mice
(Fig. 8 b), suggests that repetin is a component of the CE.
Analysis of the amino acid composition of Lor2/2 CEs
from newborn back skin indicated an approximately
threefold increase in total SPRRP proteins compared with
wild-type (Jarnik, M., P.A. de Viragh, D. Bundman, M. Si-
mon, D.R. Roop, and A.C. Stevens, manuscript submitted
for publication), which is consistent with the observed in-
crease in SPRRP2 transcripts (this study). According to
this analysis, repetin is unlikely to be a major component
of either mutant or wild-type CEs, because it is detected at
levels less than the estimated detection threshold of a few
percent. This method was not sensitive enough to detect
the increased repetin content of the CE implied by its ele-
vated transcript level. More generally, mutant CEs have
high contents of Gly and Ser, like wild-type CEs, in which
these amino acids are contributed mainly by loricrin. The
high Gly/Ser contents of the Lor2/2 mutant may be con-
tributed in part by keratins 1 and 10, whose end domains
are rich in these residues, but other components are likely
to be involved (Jarnik, M., P.A. de Viragh, D. Bundman,
M. Simon, D.R. Roop, and A.C. Stevens, manuscript sub-
mitted for publication). Moreover, our Western blot anal-
ysis and RPA of Lor2/2 epidermis did not indicate in-
creased expression of the keratins. Further studies will be
necessary to determine if a novel loricrin-like protein is in-
deed integrated into the CE of loricrin-deficient mice.
The expression of other CE components, such as involu-
crin, sciellin, filaggrin, trichohylin, and K10, were similar in
Lor2/2 and control animals. However, in the case of profil-
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aggrin, we noted an additional band in Western blots of to-
tal epidermal lysates, indicating abnormal processing of the
precursor protein. Both immunofluorescence and immuno-
electron microscopy of Lor2/2 epidermis showed a normal
distribution of profilaggrin and F-granules (data not
shown). Therefore, it is unclear whether the abnormal pro-
cessing of profilaggrin contributes to the skin phenotype of
Lor2/2 mice.
Loricrin Mutations in Vohwinkel’s Syndrome and 
Progressive Symmetric Erythrokeratoderma
Although loricrin-null mutations have not been reported in
a human skin disease, a subset of patients with Vohwinkel’s
syndrome (VS) (Maestrini et al., 1996; Korge et al., 1997;
Armstrong et al., 1998; Ishida-Yamamoto et al., 1998; Taka-
hashi et al., 1999) and one pedigree with “progressive sym-
metric erythrokeratoderma” (Ishida-Yamamoto et al.,
1997) were shown to have mutations in the loricrin gene.
These diseases are rare autosomal dominant disorders that
are clinically characterized by diffuse palmoplantar kerato-
derma (thickening of the stratum corneum of palms and
soles) with a honeycomb appearance and the development
of constricting bands around digits that can lead to auto-
amputation. In pedigrees analyzed at the molecular level,
mutations in gene sequences coding for the COOH termi-
nus of loricrin have been found (Maestrini et al., 1996;
Ishida-Yamamoto et al., 1997; Korge et al., 1997; Arm-
strong et al., 1998; Takahashi et al., 1999). All of the muta-
tions reported to date are single base pair insertions that
lead to the synthesis of an aberrant protein in which
COOH-terminal amino acid sequences are replaced by mis-
sense amino acids. These mutations also eliminate several
glutamine and lysine residues that normally form isopeptide
bonds (compare mutations reported in Maestrini et al.,
1996; Ishida-Yamamoto et al., 1997; Korge et al., 1997;
Armstrong et al., 1998; Takahashi et al., 1999; with cross-
linking sites in Candi et al., 1995; Steinert et al., 1998a).
We have recently generated a transgenic mouse model
for this disease that reproduces most of the characteristics
of VS (Suga et al., 2000). The severe phenotype resulting
from expression of the loricrin-VS mutant, as compared
with the mild Lor2/2 phenotype, suggests that it is not
functioning in a classic dominant negative fashion; it does
not produce a functional knockout of loricrin. To test this
prediction, we mated the loricrin-VS mutation into the
Lor2/2 background. The severe phenotype resulting from
this cross confirmed that the VS mutation was interfering
with late stages of epidermal differentiation in a more glo-
bal manner and did not require a direct interaction with
wild-type loricrin (Suga et al., 2000).
Implications of the Mild Transient Phenotype Resulting 
from Loss of Loricrin Expression
In summary, we have shown that in newborn mice, the
Lor2/2 phenotype includes erythroderma and a shiny,
translucent skin. The absence of a more severe phenotype
is, at least in part, due to a compensatory increase in the
expression of SPRRPs and repetin. Although CEs of mu-
tant mice show diminished stability when subjected to ex-
treme mechanical stress in vitro, we did not notice skin ab-
normalities in adult mice. This might be due to the fact
that the dense coat of mice provides protection against
mechanical stress, since the CE isolated from adult Lor2/2
mice exhibited the same susceptibility to sonication as
newborn Lor2/2 CE. This leaves one to speculate about
the potential phenotypic consequences of loricrin defi-
ciency in man. Patients born with a self-healing skin disor-
der similar to lamellar ichthyosis have been reported
(Frenk and de Techtermann, 1992), however preliminary
screening of a few of these patients did not reveal a defi-
ciency in loricrin (Hohl, D., and P. de Viragh, unpublished
data). The longer gestation time and the earlier onset of
epidermal differentiation in human embryonic develop-
ment may result in a subclinical presentation of loricrin
deficiency at birth. If human Lor2/2 CE exhibit the same
brittle characteristics as mouse Lor2/2 CE, would the ab-
sence of a dense coat of hair make these individuals more
susceptible to harsh environmental conditions such as
moisture and cold? Alternatively, are the requirements for
fully functional CE in the maintenance of epidermal bar-
rier function so critical that this need was met with the
evolution of a series of replacement components that al-
most completely compensate for each other?
In this respect, it is interesting to note that mice defi-
cient for involucrin do not develop an obvious phenotype
(Djian et al., 2000). Regardless of the answers, an under-
standing of the molecular mechanisms that allow an em-
bryo to compensate for a defect in epidermal barrier func-
tion in utero could have practical implications for the
treatment of premature infants in the future. The Lor2/2
mouse provides us with an excellent model to discover
these mechanisms.
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